HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The generation of Ig-secreting UC 729-6 derived human hybridomas by electrofusion.

Abstract
UC 729-6, a 6-thioguanine resistant human lymphoblastoid B cell line, was fused with human lymphocytes by electrofusion. Resulting human-human hybridomas were tetraploid, expressed markers derived from both fusion parents, and secreted approximately 1 microgram Ig/10(6) cells/ml/day. Cells to be used for electrofusion were washed in 0.3M mannitol, and fusions were performed with glass slides, 1.0 ml, and 50.0 ml chambers. Fusion sequences consisted of alignment, compression, and the fusion event itself. The optimal cell concentration for electrofusion was 5 X 10(6)/ml. Fusion efficiencies of human lymphocytes were ranked as follows: lymphoma cells greater than lymph node lymphocytes greater than PBL. 80% of the lymphoma hybridomas, 60% of the lymph node hybridomas, and 40% of the PBL hybridomas were Ig secretors. These data demonstrate that the UC 729-6 cell line is a suitable vector for generating human-human hybridomas by electrofusion.
AuthorsM Pratt, A Mikhalev, M C Glassy
JournalHybridoma (Hybridoma) Vol. 6 Issue 5 Pg. 469-77 (Oct 1987) ISSN: 0272-457X [Print] United States
PMID3500113 (Publication Type: Comparative Study, Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • Antibodies, Monoclonal
  • Immunoglobulin G
  • Immunoglobulin M
Topics
  • Antibodies, Monoclonal (biosynthesis)
  • B-Lymphocytes (cytology, immunology)
  • Cell Fusion
  • Cell Line
  • Electricity
  • Humans
  • Hybridomas (cytology, immunology)
  • Immunoglobulin G (biosynthesis)
  • Immunoglobulin M (biosynthesis)
  • Lymphoma (pathology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: